(Bloomberg) -- Pakistan’s OBS Group is nearing a deal to acquire pharmaceutical assets in the country from Bayer AG, according to people familiar with the matter. Most Read from BloombergXi’s Metal Curbs Risk Backfiring as G-7 Seeks China AlternativeLazard Fires Senior Banker for Inappropriate Behavior at PartyChina Restricts Export of Chipmaking Metals in Clash With USRussian General Still Missing as Defense Chief Slams MutinyStocks Decline as China Data Saps Risk Sentiment: Markets WrapThe Kar